Abstract: A phosphorus-containing ionic liquid, a phosphorus-containing a flame retardant additive, and a preparation method thereof are provided. Also provided are co-monomer salt compositions for flame retardant polymers. Also provided are polymers that comprise the phosphorus-containing flame retardant ionic liquid or flame retardant co-monomer salt. The resin composition may be used to make various articles, including fibers, fabrics, and yarns.

Abstract: Disclosure of a container to store solid and liquid wastes and perishable goods and protect them from microbial damage. The storage container is also amenable to selectively remove water vapor from inside the bag without damaging the container.

Abstract: A multifunctional polymer-free clay products having a clay, a zwitterion, a silver compound, and, an analgesic. The multifunctional polymer-free clay product provides antimicrobial and pain relieving properties. Method of treatment of burns using the multifunctional polymer-free clay product having antimicrobial and pain relieving properties. Methods of preparing multifunctional polymer-free clay products having a clay, a zwitterion, a silver compound, and, an analgesic.

Abstract: Disclosure of functionalized ionic liquids. Use of disclosed ionic liquids as solvent for carbon dioxide. Use of disclosed ionic liquids as flame retardant. Use of disclosed ionic liquids for coating fabric to obtain flame retardant fabric.

Abstract: Two siloxane-based mixtures combine to form a soft or semi-solid matrix for forming an artificial blockage to control bleeding, particularly moderate to severe bleeding. The first component includes a homogeneous mixture or solution that includes a polymeric matrix, a surfactant, filler(s) and metal compound(s). The second component includes a homogeneous mixture or solution that includes a polymer(s), a filler(s), a surfactant, and hydrogen peroxide. The combination of the two components is carried out with adequate mixing using mechanical and micro-kinetic mixing mechanisms and can be performed in a field-ready delivery device.

Abstract: A protective fabric or material includes a base material and at least one inorganic filler selected from the group consisting of a chemical decontamination agent, a biological decontamination agent, an electromagnetic radiation shielding agent, an antimicrobial agent, a self-decontaminating agent, a decontamination catalyst, a carbon dioxide absorbing agent, and a combination thereof.

Abstract: A composition for in situ formation and/or expansion of a polymer-based hemostatic agent to control bleeding includes a suitable amount of a polymer or polymer-forming component, hydrogen peroxide or chemical(s) capable of forming hydrogen peroxide, or a combination of both, and a decomposing agent for hydrogen peroxide. The decomposing agent includes an endogenously or exogenously supplied catalyst (other than catalase), or both, and/or the polymer or polymer-forming component.

Abstract: A composition for in situ formation and/or expansion of a polymer-based hemostatic agent to control bleeding includes a suitable amount of a polymer or polymer-forming component, hydrogen peroxide or chemical(s) capable of forming hydrogen peroxide, or a combination of both, and a decomposing agent for hydrogen peroxide. The decomposing agent includes an endogenously or exogenously supplied catalyst (other than catalase), or both, and/or the polymer or polymer-forming component.

Abstract: Disclosure of functionalized ionic liquids. Use of disclosed ionic liquids as solvent for carbon dioxide. Use of disclosed ionic liquids as flame retardant. Use of disclosed ionic liquids for coating fabric to obtain flame retardant fabric.

Abstract: Clay composite sheets, mats, films or membranes without polymers. Methods of preparing clay composite sheets, mats, films or membranes without using polymers in the method. Methods of using clay composite sheets, mats, films or membranes prepared without using polymers. Antimicrobial dressing having organo-modified clay product. Transdermal delivery of drugs using organo-modified clay product and methods.

Abstract: A composition for in situ formation of an artificial blockage to control bleeding includes a suitable amount of a polymer-forming component, a suitable amount of a crosslinking agent, hydrogen peroxide, and a decomposing agent for hydrogen peroxide. The decomposing agent includes exogenous or endogenous catalase, or both.

Abstract: A method of preparing a metal nitride and/or metal oxynitride particulate material includes heating a stoichiometric mixture of a metal compound and urea at a temperature of about 400-1000° C. for a predetermined time period in the presence of argon, nitrogen, or both. The particulate material produced includes nanoparticles, nanotubes, microparticles, powder, or a combination thereof.

Abstract: Two siloxane-based mixtures combine to form a soft or semi-solid matrix for forming an artificial blockage to control bleeding, particularly moderate to severe bleeding. The first component includes a homogeneous mixture or solution that includes a polymeric matrix, a surfactant, filler(s) and metal compound(s). The second component includes a homogeneous mixture or solution that includes a polymer(s), a filler(s), a surfactant, and hydrogen peroxide. The combination of the two components is carried out with adequate mixing using mechanical and micro-kinetic mixing mechanisms and can be performed in a field-ready delivery device.

Abstract: A hemostatic composition includes a carrier medium including a predetermined amount of a particulate material. The particulate material is comprised of core particles with a coating. The core particles have an average particle size of about 5 nm to 10 ?m, and the coating is one of gold, silica, silver, platinum, steel, cobalt, carbon, a polymer, or a combination thereof.

Abstract: A composition for in situ formation of an artificial blockage to control bleeding includes a suitable amount of a polymer-forming component, a suitable amount of a crosslinking agent, hydrogen peroxide, and a decomposing agent for hydrogen peroxide. The decomposing agent includes exogenous or endogenous catalase, or both.

Abstract: A multifunctional particulate material, fluid, or composition includes a predetermined amount of core particles with a plurality of coatings. The core particles have an average particle size of about 1 nm to 500 ?m. The particulate material, fluid, or composition is capable of exhibiting one or more properties, such as magnetic, thermal, optical, electrical, biological, chemical, lubrication, and rheological.

Abstract: A method and kit for inducing hypoxia in tumors includes impeding oxygen supply to non-hypoxic cells in a subject in need thereof by using a magnetic fluid.

Abstract: A cushioning device for a footwear or shoe includes a chamber with a magnetically responsive fluid therein for absorbing and/or dampening vibrations and/or shocks. A magnetic member, such as an electromagnet, is provided for applying a magnetic field to the magnetic fluid to thereby vary the viscosity thereof.

Abstract: An airbag inflation apparatus includes a chamber for generating a gas to inflate an airbag. A valve, including a magnetic fluid and a source of magnetic field, preferably an electromagnet, is associated with the chamber for regulating the flow of the gas into the airbag. A sensor determines and feeds occupant information to the sensor.

Abstract: A device for generating power includes a fluid including magnetic particles. A source magnetizes the fluid thereby inducing rotations in the magnetic particles for creating a magnetic flux. The rotations of the magnetic particles induce an electromagnetic force in a coil associated with the fluid.